1. |
Miranda-Filho A, Piñeros M, Ferreccio C, et al. Gallbladder and extrahepatic bile duct cancers in the Americas: incidence and mortality patterns and trends. Int J Cancer, 2020, 147(4): 978-989.
|
2. |
孙旭恒, 王一钧, 张薇, 等. 中国胆囊癌流行病学特征与诊治及预后分析(附6 159例报告). 中华消化外科杂志, 2022, 21(1): 114-128.
|
3. |
Zhu AX, Pawlik TM, Kooby DA, et al. Gallbladder//Amin MB. AJCC cancer staging manual. 8th ed. New York: Springer, 2017: 303-309.
|
4. |
胆道肿瘤专家委员会. CSCO胆道系统肿瘤诊断治疗专家共识(2019年版). 临床肿瘤学杂志, 2019, 24(9): 828-838.
|
5. |
中华医学会外科学分会胆道外科学组, 中国医师协会外科医师分会胆道外科专业委员会. 胆囊癌诊断和治疗指南(2019版). 中华外科杂志, 2020, 58(4): 243-251.
|
6. |
Lee W, Jeong CY, Jang JY, et al. Do hepatic-sided tumors require more extensive resection than peritoneal-sided tumors in patients with T2 gallbladder cancer? Results of a retrospective multicenter study. Surgery, 2017, 162(3): 515-524.
|
7. |
刘鹏, 张贤彬, 耿智敏, 等. 不同手术方式治疗T1b期胆囊癌效果的多中心研究. 中华外科杂志, 2018, 56(5): 355-359.
|
8. |
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6 336 patients and results of a survey. Ann Surg, 2004, 240(2): 205-213.
|
9. |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71(3): 209-249.
|
10. |
Cho JK, Lee W, Jang JY, et al. Validation of the oncologic effect of hepatic resection for T2 gallbladder cancer: a retrospective study. World J Surg Oncol, 2019, 17(1): 8. doi: 10.1186/s12957-018-1556-6.
|
11. |
Li G, Kim JH, Jung W, et al. Significance of hepatectomy in patients diagnosed with T2 gallbladder cancer. Surg Laparosc Endosc Percutan Tech, 2020, 30(1): 35-39.
|
12. |
Khan SM, Emile SH, Choudhry MS, et al. Tumor location and concurrent liver resection, impact survival in T2 gallbladder cancer: a meta-analysis of the literature. Updates Surg, 2021, 73(5): 1717-1726.
|
13. |
Kwon W, Kim H, Han Y, et al. Role of tumour location and surgical extent on prognosis in T2 gallbladder cancer: an international multicentre study. Br J Surg, 2020, 107(10): 1334-1343.
|
14. |
Lafaro K, Blakely AM, Melstrom LG, et al. Prognostic impact of tumor location in resected gallbladder cancer: a national cohort analysis. J Surg Oncol, 2020, 122(6): 1084-1093.
|
15. |
滕达, 刘鹏, 耿智敏, 等. T1、T2期胆囊癌手术方式选择. 中华肝脏外科手术学电子杂志, 2021, 10(1): 24-28.
|
16. |
孙培伟, 滕达, 巩鹏. 新分期带来的胆囊癌手术范围合理性的争议. 西安交通大学学报(医学版), 2021, 42(1): 7-10, 58.
|
17. |
王泽宇, 黑振宇, 耿亚军, 等. 基于TNM分期的胆囊癌手术治疗. 中国实用外科杂志, 2021, 41(2): 236-238.
|
18. |
Kim WJ, Lim TW, Park PJ, et al. Clinicopathological differences in T2 gallbladder cancer according to tumor location. Cancer Control, 2020, 27(1): 1073274820915514. doi: 10.1177/1073274820915514.
|
19. |
Chen M, Cao J, Xiang Y, et al. Hepatectomy strategy for T2 gallbladder cancer between segment Ⅳb and Ⅴ resection and wedge resection: a propensity score-matched study. Surgery, 2021, 169(6): 1304-1311.
|
20. |
Nag HH, Nekarakanti PK, Sachan A, et al. Bi-segmentectomy versus wedge hepatic resection in extended cholecystectomy for T2 and T3 gallbladder cancer: a matched case-control study. Ann Hepatobiliary Pancreat Surg, 2021, 25(4): 485-491.
|